Coding and marking specialist Domino Printing Sciences has joined forces with vision and automation business Omron, as part of Domino’s i-Tech Partner Programme, to assist manufacturers with the alignment of their printing and vision systems.
Focusing initially on the pharmaceutical sector, where impending legislation will require a new level of rigour in coding, marking and verification operations, the partnership will ultimately offer benefits to Domino customers across a range of industries.
As part of Domino’s Partner Programme, through which Domino will work with partners to offer software solutions for mass serialisation, Omron will team with Domino to deliver proven technology to meet pharmaceutical quality standards for legislation such as the EU Falsified Medicines Directive (FMD), set to be in place by 2018.
For manufacturers who are purchasing their own components for packaging lines to comply with the upcoming FMD legislation, Domino and Omron will provide printing and vision equipment that is guaranteed to integrate with them, and offer tangible benefits to operating efficiency.
Our partnership with Domino means that we can provide tested and proven technology to our mutual customers
A key advantage of the partnership is the experience both companies have in other sectors, where solutions offer significant print speed advantages and code reading stability. These advantages are an important factor for manufacturers as they tackle one of the pharmaceutical industry’s biggest challenges yet – moving from batch code to individual pack code serialisation.
'Our partnership with Domino means that we can provide tested and proven technology to our mutual customers,' said Gunnar Bischoff, business model and industry marketing for Omron. 'Our partnership goes beyond products – it provides reassurance to our customers that Domino’s printers and our automation and inspection systems can be integrated into the same applications.'
Craig Stobie, Head of the Global Life Sciences team at Domino, said: 'Our printing technology alongside Omron’s market leading vision and automation expertise will be of great benefit to pharmaceutical manufacturers. When many vision partners are focused on data management, it is great to have a partner experienced in the pharmaceutical sector who is focused purely on vision for quality purposes.
'When developing a custom-built solution as the FMD legislation date edges closer, manufacturers need to know that the components they are using work well together and will help to smooth out the process of upgrading. Our partnership with Omron aims to give this assurance.'